ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $39,595 | -62.3% | 61,000 | 0.0% | 0.00% | -66.7% |
Q3 2022 | $105,000 | +38.2% | 61,000 | 0.0% | 0.01% | +50.0% |
Q2 2022 | $76,000 | +90.0% | 61,000 | 0.0% | 0.01% | +200.0% |
Q1 2022 | $40,000 | -39.4% | 61,000 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $66,000 | +17.9% | 61,000 | +96.8% | 0.00% | 0.0% |
Q3 2021 | $56,000 | -31.7% | 31,000 | 0.0% | 0.00% | -20.0% |
Q2 2021 | $82,000 | -26.8% | 31,000 | 0.0% | 0.01% | -37.5% |
Q1 2021 | $112,000 | +43.6% | 31,000 | 0.0% | 0.01% | +60.0% |
Q4 2020 | $78,000 | 0.0% | 31,000 | 0.0% | 0.01% | -16.7% |
Q3 2020 | $78,000 | -23.5% | 31,000 | 0.0% | 0.01% | -25.0% |
Q2 2020 | $102,000 | +37.8% | 31,000 | +3.3% | 0.01% | +14.3% |
Q1 2020 | $74,000 | -43.9% | 30,000 | +7.1% | 0.01% | -30.0% |
Q4 2019 | $132,000 | +10.0% | 28,000 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $120,000 | -26.4% | 28,000 | 0.0% | 0.01% | -28.6% |
Q2 2019 | $163,000 | +40.5% | 28,000 | -6.7% | 0.01% | +40.0% |
Q1 2019 | $116,000 | +107.1% | 30,000 | 0.0% | 0.01% | +66.7% |
Q4 2018 | $56,000 | – | 30,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
G&S Capital LLC | 18,000 | $34,000 | 0.03% |